Cerner Co. (NASDAQ:CERN – Get Rating) has earned a consensus rating of “Hold” from the eleven research firms that are currently covering the company, Marketbeat reports. Eight equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $87.00.
A number of brokerages have commented on CERN. StockNews.com began coverage on shares of Cerner in a research report on Thursday, March 31st. They set a “buy” rating on the stock. Argus lowered Cerner from a “buy” rating to a “hold” rating in a research note on Monday, April 11th.
Shares of NASDAQ CERN opened at $93.34 on Friday. Cerner has a one year low of $69.08 and a one year high of $93.87. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.51 and a quick ratio of 1.49. The firm’s 50 day simple moving average is $93.17 and its two-hundred day simple moving average is $85.49. The stock has a market capitalization of $27.44 billion, a P/E ratio of 50.45, a PEG ratio of 2.36 and a beta of 0.82.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 19th. Stockholders of record on Monday, March 28th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend was Friday, March 25th. Cerner’s dividend payout ratio (DPR) is presently 58.38%.
In related news, insider Tracy L. Platt sold 7,769 shares of the firm’s stock in a transaction on Friday, March 11th. The stock was sold at an average price of $93.40, for a total value of $725,624.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.18% of the company’s stock.
A number of hedge funds have recently made changes to their positions in CERN. Strs Ohio increased its holdings in shares of Cerner by 249.4% during the first quarter. Strs Ohio now owns 37,543 shares of the company’s stock valued at $3,512,000 after acquiring an additional 26,798 shares in the last quarter. Inspire Investing LLC bought a new stake in Cerner in the 1st quarter worth about $412,000. Cardinal Capital Management increased its holdings in Cerner by 2.9% in the 1st quarter. Cardinal Capital Management now owns 51,981 shares of the company’s stock worth $4,863,000 after buying an additional 1,471 shares in the last quarter. Elevated Capital Advisors LLC bought a new stake in shares of Cerner during the 1st quarter valued at about $266,000. Finally, Avity Investment Management Inc. grew its stake in shares of Cerner by 142.5% during the 1st quarter. Avity Investment Management Inc. now owns 9,700 shares of the company’s stock valued at $908,000 after purchasing an additional 5,700 shares during the period. 83.96% of the stock is owned by institutional investors.
Cerner Company Profile (Get Rating)
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
- Get a free copy of the StockNews.com research report on Cerner (CERN)
- NextEra Energy Offers a Long-Term Gain if You Can Tolerate Short-Term Pain
- Steel Dynamics Scales New Heights On Record Results
- Tesla (NASDAQ: TSLA) Stock Hits Four Figures Once Again
- The Institutions Are Driving Knight-Swift Transportation
- 3 Legendary Low-Beta Stocks Set to Outperform
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.